BioViva CEO On Becoming the First Gene Therapy Test Subject

“If you could do one action that might save a thousand, a million or a billion people—but you might die from doing it? Why would you take the risk?”

Elizabeth Parrish, the 44-year old Ceo of BioViva would. In fact, she’s claiming that recently became the world’s first gene therapy test subject. This video is a trailer for an upcoming interview where she discusses the implications of becmoing “Patient Zero.”